Detalhe da pesquisa
1.
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
Cell
; 153(5): 1064-79, 2013 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706743
2.
Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.
Annu Rev Pharmacol Toxicol
; 64: 455-479, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738504
3.
Functional genomic landscape of acute myeloid leukaemia.
Nature
; 562(7728): 526-531, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333627
4.
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia.
Br J Haematol
; 200(3): 323-328, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264026
5.
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 117(25): 14331-14341, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513686
6.
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.
Blood
; 135(24): 2159-2170, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315394
7.
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.
Invest New Drugs
; 39(3): 736-746, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403501
8.
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Proc Natl Acad Sci U S A
; 114(36): E7554-E7563, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784769
9.
Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation.
J Biol Chem
; 293(32): 12502-12515, 2018 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903916
10.
Oncoproteomic profiling of AML: moving beyond genomics.
Expert Rev Proteomics
; 19(7-12): 283-287, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734985
11.
Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens.
J Pediatr Hematol Oncol
; 39(7): e359-e366, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28906323
12.
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
N Engl J Med
; 368(19): 1781-90, 2013 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23656643
13.
A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance.
Am J Hematol
; 96(7): E226-E229, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780043
14.
Detecting and targetting oncogenic fusion proteins in the genomic era.
Biol Cell
; 107(5): 111-29, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25631473
15.
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.
Cancer Cell
; 12(6): 542-58, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18068631
16.
On translational regulation and EMT.
Semin Cancer Biol
; 22(5-6): 437-45, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22554796
17.
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia.
Cell Rep Med
; 5(1): 101359, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232702
18.
Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
Cold Spring Harb Mol Case Stud
; 8(6)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307214
19.
Evaluation of Differential Peptide Loading on Tandem Mass Tag-Based Proteomic and Phosphoproteomic Data Quality.
J Am Soc Mass Spectrom
; 33(1): 17-30, 2022 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34813325
20.
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Cancer Cell
; 40(8): 850-864.e9, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868306